Schrodinger, Inc. ($SDGR)
Filing Information
| Accession Number | 0001797672-26-000006 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 21, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
94,797
Total Value
$1,065,109.66
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
President, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships | Common Stock | โ | Sep 17, 2026 | Exercise/Conversion | 31,599 | $4.34 | $137,139.66 | 101,555 | Direct | โ | View Details | |
President, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships | Common Stock | โ | Sep 17, 2026 | Sale | 10,000 | $28.00 | $280,000.00 | 91,555 | Direct | โ | View Details | |
President, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships | Common Stock | โ | Sep 17, 2026 | Sale | 21,599 | $30.00 | $647,970.00 | 69,956 | Direct | โ | View Details | |
President, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships | Stock Option (right to buy) | Derivative | Sep 17, 2026 | Exercise/Conversion | 31,599 | $0.00 | $0.00 | 11,599 | Direct | โ | View Details |